Drugs / IPV
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01709071 Comparator | Feb → Nov 2012 | poliomyelitis | Pauline Verdijk | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01709071 ↗ |
| Known as | wIPV | “Healthy infants (n=20/group) aged 56-63 days, received a primary series of three intramuscular injections with low-, middle- or high-dose sIPV with or without aluminum...” PMID 25043278 ↗ Jul 2014 |
| Modality | Vaccine | “An inactivated poliovirus vaccine (IPV) based on attenuated poliovirus strains (Sabin-1, -2 and -3) was developed” PMID 25043278 ↗ Jul 2014 |